- Home
- EPOW vs COEP Comparison
EPOW vs COEP Comparison
Compare EPOW & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPOW
- COEP
- Stock Information
- Founded
- EPOW 2014
- COEP 2017
- Country
- EPOW China
- COEP United States
- Employees
- EPOW N/A
- COEP N/A
- Industry
- EPOW Business Services
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EPOW Consumer Discretionary
- COEP Health Care
- Exchange
- EPOW Nasdaq
- COEP Nasdaq
- Market Cap
- EPOW 27.0M
- COEP 32.0M
- IPO Year
- EPOW 2021
- COEP N/A
- Fundamental
- Price
- EPOW $0.92
- COEP $9.23
- Analyst Decision
- EPOW
- COEP
- Analyst Count
- EPOW 0
- COEP 0
- Target Price
- EPOW N/A
- COEP N/A
- AVG Volume (30 Days)
- EPOW 24.6K
- COEP 28.6K
- Earning Date
- EPOW 06-17-2025
- COEP 05-14-2025
- Dividend Yield
- EPOW N/A
- COEP N/A
- EPS Growth
- EPOW N/A
- COEP N/A
- EPS
- EPOW N/A
- COEP N/A
- Revenue
- EPOW $64,997,741.00
- COEP $62,874.00
- Revenue This Year
- EPOW N/A
- COEP N/A
- Revenue Next Year
- EPOW N/A
- COEP N/A
- P/E Ratio
- EPOW N/A
- COEP N/A
- Revenue Growth
- EPOW 44.28
- COEP N/A
- 52 Week Low
- EPOW $0.53
- COEP $2.31
- 52 Week High
- EPOW $1.36
- COEP $13.70
- Technical
- Relative Strength Index (RSI)
- EPOW 52.18
- COEP 42.98
- Support Level
- EPOW $0.90
- COEP $9.14
- Resistance Level
- EPOW $1.01
- COEP $9.82
- Average True Range (ATR)
- EPOW 0.06
- COEP 0.48
- MACD
- EPOW 0.00
- COEP -0.08
- Stochastic Oscillator
- EPOW 65.31
- COEP 0.88
About EPOW Sunrise New Energy Co. Ltd
Sunrise New Energy Co Ltd is engaged in the manufacturing and sale of graphite anode material for EVs and other lithium-ion batteries. The Company's joint venture is into the construction of a manufacturing plant in Guizhou Province. The plant runs on inexpensive electricity from renewable sources that enables the group to be a low-cost and low environmental impact producer of graphite anode material, Its products include GS-1, GS-2, GS-3, GZD-1, GLD-1, and GZ-1.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.